Last updated: December 14, 2020
Sponsor: Children's Hospital of Fudan University
Overall Status: Trial Not Available
Phase
3
Condition
Nephropathy
Kidney Failure (Pediatric)
Allergies & Asthma
Treatment
N/AClinical Study ID
NCT04536181
CSICS
Ages 1-6 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Idiopathic, steroid-sensitive, first episode of nephrotic syndrome
- Age 12 months up to 6 years
- Written informed consent
Exclusion
Exclusion Criteria:
- Nephrotic syndrome known to be secondary to a systemic disorder, e.g., ImmunoglobulinA (IgA) nephropathy, systemic lupus erythematosus, Henoch Schonlein purpura,vasculitis, , hepatitis B or Alport syndrome.
- Therapy with prednisolone for prior episodes of nephrotic syndrome
- Persistent estimated glomerular filtration rate (GFR) <75 ml/min/1.73 m2
- Patients who show relapse during the first 3 months of pre-randomizationcorticosteroid therapy for nephrotic syndrome
- Patients with initial steroid resistance
- Patients who are allergic to glucocorticoids
- The compliance of patients or their guardians is poor
Study Design
Study Start date:
January 01, 2021
Estimated Completion Date:
October 01, 2022
Connect with a study center
Children's hospital of Fudan university
Shanghai, Shanghai 200000
ChinaSite Not Available
Shanghai Children's Hospital
Shanghai,
ChinaSite Not Available
Shanghai Children's Medical Center
Shanghai,
ChinaSite Not Available
Xinhua Hospital, Shanghai Jiaotong University School of Medicine
Shanghai,
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.